Overview
Status
Active
Registry date
2006-05-30
Share capital
30,000.00 PLN
Registered address
Sasanki 16, 05-509 Józefosław, Poland
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 13 days early.
- 202511/07/2026
- 202413/07/2025
- 202307/07/2024
- 202230/06/2023
- 202111/07/2022
- 202002/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 37.74kMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 11.34kMedianUSD 20.66kAverageUSD 86.55k
Operating costs
This companyUSD 19.88kMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 225.52kMedianUSD 544.32kAverageUSD 1.76m
Industry
Authorized Representatives
Beata Joanna Charchalis – President of the Management Board
Lubomir Charchalis – Attorney-in-fact (sole)
Manner of representation
Each member of the management board is independently authorised to make declarations of will and sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Beata Joanna Charchalisage 59 | 420 | $5,672.61 | 70% |
Lubomir Charchalisage 60 | 180 | $2,431.12 | 30% |
Beata Joanna Charchalis and Lubomir Charchalis hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2006-08-02.
25 1240 1109 1111 0010 1185 5731
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Nov 25, 2016 | Call to creditors |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| DR ZdrowieS.A. | $40,415,498.47 | drzdrowie.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Adpharmasp. z o.o. | $4,026,799.19 | adamed.com | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| MaglowS.A. | $1,356,219.12 | maglow.pl | ||
| Farmacja Im. O. Klimuszkisp. z o.o. | $1,289,548.20 | zyj-zdrowo.com | ||
| Nukloversp. z o.o. | $227,479.26 | nuklover.com | ||
| Massmedsp. z o.o. | $49,747.70 | mojoapps.co | ||
| DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A. | $2,740.83 | kwendasa.pl | ||
| Femaherbsp. z o.o. | $655.76 | femaherb.com |
Change history
| Date | Event | |
|---|---|---|
| 2017-03-27 | Share capital reduction (300,000.00 PLN → 30,000.00 PLN) | |
| 2017-03-27 | PKD change (Removed: 70.21.Z) | |
| 2009-02-03 | Name change (Ima Pharma → Lubo Pharma) | |
| 2009-02-03 | Switch to PKD 2007 (9 PKD 2004 codes → 11 PKD 2007 codes) | |
| 2006-11-13 | Address change (F.joliot-Curie 26/8, 02-646, Warszawa → Sasanki 16, 05-509, Józefosław) |
FAQ
The main business activity of Lubo Pharma focuses on dispensing chemist in specialised stores.
The company was registered in the Polish National Court Register (KRS) on May 30, 2006.
The headquarters is located at: Sasanki 16, 05-509 Józefosław.
The share capital of the company is PLN 30,000 (approx. $8,104).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $43,726 in 2024, which is an increase of 38.7% compared to 2023.
Yes, the company recorded a net profit of $12,302 in 2024.
The largest operating cost category falls under depreciation and amortization. This category amounted to $11,734 in 2024, representing 49% of all operating expenses.
Last updated: 2026-07-16